Literature DB >> 17883982

Acute pancreatitis: practical considerations in nutrition support.

Leah Gramlich1, And Kendall Taft.   

Abstract

Acute pancreatitis is a clinical syndrome defined by a discrete episode of abdominal pain and elevations in serum enzyme levels. Seventy-five percent to 85% of all pancreatic episodes are considered mild and self-limiting and do not require intervention with nutrition support. Considering the significant risk of malnutrition in moderate to severe forms of pancreatic injury, enteral nutrition has more recently been documented in its benefit as an adjunct to management. In addition, it may play a role in obviating the systemic inflammatory response syndrome and in modifying the course of the disease. This paper reviews practical considerations in feeding patients with severe acute pancreatitis, including discussion of gastric versus post-pyloric feeding, choice of enteral product, and relative role and optimization of parenteral nutrition support.

Entities:  

Mesh:

Year:  2007        PMID: 17883982     DOI: 10.1007/s11894-007-0037-9

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  40 in total

1.  Physiological effects of enteral and parenteral feeding on pancreaticobiliary secretion in humans.

Authors:  Stephen J D O'Keefe; Ronzo B Lee; Frank P Anderson; Chris Gennings; Souheil Abou-Assi; John Clore; Douglas Heuman; William Chey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-01       Impact factor: 4.052

2.  Enteral nutrition in acute pancreatitis: a survey of practices in canadian intensive care units.

Authors:  Jan K Greenwood; Heather Y Lovelace; Stephen A McClave
Journal:  Nutr Clin Pract       Date:  2004-02       Impact factor: 3.080

3.  A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis.

Authors:  F C Eatock; P Chong; N Menezes; L Murray; C J McKay; C R Carter; C W Imrie
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

4.  Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis--a prospective randomized clinical trial.

Authors:  Natalia Lasztity; Jozsef Hamvas; Lajos Biró; Eva Németh; Tamas Marosvölgyi; Tamás Decsi; Akos Pap; Magda Antal
Journal:  Clin Nutr       Date:  2005-04       Impact factor: 7.324

5.  [Combination of early nasojejunal feeding with modern synbiotic therapy in the treatment of severe acute pancreatitis (prospective, randomized, double-blind study)].

Authors:  Attila Oláh; Tibor Belágyi; Akos Issekutz; Gábor Olgyai
Journal:  Magy Seb       Date:  2005-06

6.  Semi-elemental formula or polymeric formula: is there a better choice for enteral nutrition in acute pancreatitis? Randomized comparative study.

Authors:  Laurent-Eric Tiengou; Romain Gloro; Julien Pouzoulet; Karine Bouhier; Marie-Hélène Read; Franck Arnaud-Battandier; Jean-Marie Plaze; Xavier Blaizot; Thông Dao; Marie-Astrid Piquet
Journal:  JPEN J Parenter Enteral Nutr       Date:  2006 Jan-Feb       Impact factor: 4.016

7.  Acute pancreatitis: value of CT in establishing prognosis.

Authors:  E J Balthazar; D L Robinson; A J Megibow; J H Ranson
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

Review 8.  Nutrition support in acute pancreatitis: a systematic review of the literature.

Authors:  Stephen A McClave; Wei-Kuo Chang; Rupinder Dhaliwal; Daren K Heyland
Journal:  JPEN J Parenter Enteral Nutr       Date:  2006 Mar-Apr       Impact factor: 4.016

Review 9.  Clinical potential of insulin therapy in critically ill patients.

Authors:  Dieter Mesotten; Greet Van den Berghe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Gastric versus post-pyloric feeding: a systematic review.

Authors:  Paul E Marik; Gary P Zaloga
Journal:  Crit Care       Date:  2003-05-06       Impact factor: 9.097

View more
  1 in total

Review 1.  Nutrition management in acute pancreatitis: Clinical practice consideration.

Authors:  Narisorn Lakananurak; Leah Gramlich
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.